SHELTON, Conn., July 7 /PRNewswire/ -- iMedX Inc., a leading healthcare software and services company, announced today that it has acquired Medware Inc. With this acquisition, iMedX expands its reach into the hospital market and emerges as one of the largest medical transcription companies in the United States.
Based just outside of Orlando, Florida, Medware currently serves over sixty health systems across the country, utilizing a labor force of over 350 US-based medical language specialists. As a result of this significant acquisition iMedX will benefit from greater penetration into the large health system market. Medware's fifteen-years of experience providing high quality transcription services to leading hospitals and clinics will augment iMedX's reputation as a quality leader in technology-enabled medical documentation services.
Venkat Sharma, iMedX's President and CEO, along with the current iMedX management team, will continue to lead the combined companies. Medware will operate as a division of iMedX, with Medware's experienced production and operational team joining iMedX to create a stronger combined customer-facing organization.
"This acquisition offers significant advantages to iMedX in terms of strengthening revenue and operational efficiencies and by gaining new opportunities to deliver leading-edge Internet-based technology and services to our combined customer base," said Mr. Sharma. "Our customers will benefit because all of our solutions are designed to improve their efficiency, accuracy and ultimately, the quality of care in the dynamic healthcare industry."
iMedX is a leading US-based outsource provider of healthcare software and services to hospitals and medical practices throughout the U.S. iMedX's innovative Internet-based transcription delivery platform, TurboScribe(R) is used by thousands of providers across the United States. High quality transcription services are provided through delivery centers in the U.S. and India. iMedX's new TurboRecord(R) electronic medical record service and an e-Prescription platform TurboRx(R) allows doctors to comply with HIPAA guidelines and minimize costs. iMedX is headquartered in Shelton, Connecticut. For more information please visit www.imedx.com.
|SOURCE iMedX Inc.|
Copyright©2009 PR Newswire.
All rights reserved